Ezra Abrams

Dr. Abrams has broad knowledge in molecular biology and protein science. He has been a Research Director or Principal Scientist at a number of firms, including First Light Biosciences, Mosaic Technologies and Praecis Pharmaceuticals. Dr. Abrams focus has been the discovery and development of novel technologies, and these efforts have resulted in the products in the areas of microarrays, immunoassays, and drug discovery. At Mosaic, Dr. Abrams was the lead developer of bridge amplification, the basis of Illumina sequencing technology. Dr. Abrams holds a Ph.D from the Albert Einstein College of Medicine.